GO:0004139 deoxyribose-phosphate aldolase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0004139 (deoxyribose-phosphate aldolase activity) catalyzes the reversible cleavage of 2-deoxy-D-ribose 5-phosphate into D-glyceraldehyde 3-phosphate and acetaldehyde, a key step in deoxyribose catabolism.
The enzyme is widely distributed across bacteria, archaea, and eukaryotes; in humans the DERA protein is the functional deoxyribose phosphate aldolase and participates in stress responses.
The catalytic mechanism relies on a conserved lysine residue that forms a Schiff base with the substrate, a feature confirmed by structural and mutagenesis studies.
Beyond its catabolic role, DERA is a valuable biocatalyst for stereoselective carbon-carbon bond formation, enabling the synthesis of chiral intermediates such as (R)-1,3-butanediol.
Bacterial DERA enzymes from Bacillus, Paenibacillus, and Streptococcus species have been purified and characterized, revealing diverse substrate tolerances and kinetic properties.
CRISPR-based knockout, point-mutation, and overexpression models are essential to dissect DERA function in cellular stress responses and metabolic pathways.

Description

Deoxyribose-phosphate aldolase activity (GO:0004139) is a molecular function that catalyzes the reversible aldol cleavage of 2-deoxy-D-ribose 5-phosphate to produce D-glyceraldehyde 3-phosphate and acetaldehyde. This reaction is a central step in the catabolism of deoxyribose, allowing cells to salvage and recycle deoxyribonucleotides. The enzyme responsible, often called DERA or deoxyriboaldolase, is found in organisms ranging from bacteria to humans. In bacteria such as Bacillus cereus and Bacillus altitudinis, the enzyme has been purified and biochemically characterized, showing its importance in deoxyribose utilization. In humans, the DERA protein is the functional deoxyribose phosphate aldolase and is involved in stress responses, suggesting a role beyond simple catabolism. The reaction is also of interest for biocatalysis because it forms carbon-carbon bonds stereoselectively, making it a target for engineering novel biosynthetic pathways. Understanding GO:0004139 is therefore relevant for microbiologists, enzymologists, and metabolic engineers alike.

deoxyribose-phosphate aldolase activity At A Glance

GO ID GO:0004139
GO term deoxyribose-phosphate aldolase activity
Ontology molecular_function
Synonym 2-deoxy-D-ribose-5-phosphate acetaldehyde-lyase activity; deoxyriboaldolase activity; phosphodeoxyriboaldolase activity
Major function Catalyzes the reversible cleavage of 2-deoxy-D-ribose 5-phosphate to D-glyceraldehyde 3-phosphate and acetaldehyde
Reaction direction Reversible aldol cleavage/condensation
Substrate 2-deoxy-D-ribose 5-phosphate
Products D-glyceraldehyde 3-phosphate and acetaldehyde
Cofactor None required; uses a conserved lysine for Schiff base formation

What Is GO:0004139?

According to the Gene Ontology, GO:0004139 (deoxyribose-phosphate aldolase activity) is defined as the catalysis of the reaction: 2-deoxy-D-ribose 5-phosphate = D-glyceraldehyde 3-phosphate + acetaldehyde. In other words, it is an enzyme activity that breaks down a phosphorylated deoxyribose sugar into two smaller molecules, a reaction that can also proceed in reverse to form the sugar-phosphate. This activity is synonymous with deoxyriboaldolase, phosphodeoxyriboaldolase, and 2-deoxyribose-5-phosphate aldolase activity.

Why Is deoxyribose-phosphate aldolase activity Important in Cell Biology?

GO:0004139 is important because it represents a key enzymatic step in deoxyribose catabolism, allowing cells to utilize deoxyribose as a carbon and energy source. In humans, the DERA enzyme is implicated in stress responses, and its dysfunction may affect nucleotide homeostasis. In biotechnology, DERA is a promising biocatalyst for the stereoselective synthesis of chiral compounds, including pharmaceutical intermediates. Moreover, the enzyme is a potential target for antibacterial drug development, as many pathogens rely on deoxyribose salvage pathways.
Central to deoxyribose catabolism and nucleotide salvage.
Human DERA is involved in cellular stress responses.
Bacterial DERA enzymes are potential antibacterial targets.
DERA is used as a biocatalyst for stereoselective aldol additions.
Enables biosynthesis of (R)-1,3-butanediol and other chiral building blocks.
Provides a model system for studying enzyme mechanism and substrate specificity.
Relevant to metabolic engineering of pathways for industrial chemicals.
Contributes to understanding of deoxyribonucleoside metabolism in pathogens.

Molecular Mechanism of deoxyribose-phosphate aldolase activity

Substrate Binding and Schiff Base Formation
In simple terms: The enzyme grabs the sugar-phosphate substrate and forms a temporary chemical bond with it.
The catalytic mechanism of deoxyribose-phosphate aldolase (DERA) begins with the binding of 2-deoxy-D-ribose 5-phosphate in the active site. A conserved lysine residue attacks the carbonyl group of the substrate to form a Schiff base intermediate, as demonstrated by structural and mutagenesis studies. This covalent intermediate is essential for the subsequent aldol cleavage.
Aldol Cleavage and Product Release
In simple terms: The enzyme then breaks the sugar into two smaller molecules, which are released.
Following Schiff base formation, the enzyme catalyzes the retro-aldol cleavage of the substrate, yielding D-glyceraldehyde 3-phosphate and acetaldehyde. The reaction is reversible, and the enzyme can also catalyze the condensation of these two products under appropriate conditions. Product release completes the catalytic cycle.
Substrate Specificity and Structural Determinants
In simple terms: The shape of the enzyme's active site determines which molecules it can act on.
Structural studies of DERA from Streptococcus suis and other organisms have revealed that substrate tolerance is governed by the size and hydrophobicity of the active site pocket. Mutagenesis of key residues can expand substrate specificity, enabling the use of non-natural substrates for biocatalysis. This plasticity is exploited in engineering DERA for synthetic applications.
Kinetic Properties and Regulation
In simple terms: The speed of the reaction can vary, and the enzyme may be controlled by cellular conditions.
Kinetic characterization of DERA from Bacillus cereus, Paenibacillus sp., and Bacillus altitudinis has provided insights into its catalytic efficiency and substrate affinity. The enzyme does not require metal cofactors, but its activity can be influenced by pH and temperature. In humans, DERA expression is upregulated under stress conditions, suggesting transcriptional regulation.

Key Genes Involved in GO:0004139 deoxyribose-phosphate aldolase activity

The following genes and proteins are directly associated with deoxyribose-phosphate aldolase activity (GO:0004139) based on published biochemical and structural studies.
GeneMajor RoleResearch Relevance
DERA (human)Human deoxyribose phosphate aldolase; involved in stress responseStudied for its role in cellular stress and nucleotide metabolism
deaD (Bacillus altitudinis)Deoxyribose-phosphate aldolaseCharacterized for industrial and biocatalytic applications
dra (Bacillus cereus)Deoxyribose 5-phosphate aldolasePurified and biochemically characterized
deaD (Streptococcus suis)2-deoxyribose-5-phosphate aldolaseStructural insights into substrate tolerance
DERA (engineered variants)Rational engineering for (R)-1,3-butanediol biosynthesisBiocatalyst optimization
DERA (E. coli)Model enzyme for structure-based mutagenesisSubstrate specificity expansion
DERA (newly synthesized)Characterization and applicationIndustrial biocatalysis
DERA (Paenibacillus sp. EA001)Novel deoxyribose 5-phosphate aldolaseExpression and characterization
DERA (Thermotoga maritima)Thermostable DERAStructural studies
DERA (Archaeoglobus fulgidus)Hyperthermophilic DERABiocatalysis
DERA (Klebsiella pneumoniae)Deoxyribose-phosphate aldolaseMetabolic engineering
DERA (Salmonella enterica)Deoxyribose catabolismPathogen metabolism
DERA (Lactobacillus)Probiotic deoxyribose utilizationMicrobiome studies
DERA (Mycobacterium tuberculosis)Potential drug targetAntibacterial development
DERA (yeast)Deoxyribose phosphate aldolaseEukaryotic model

How Is deoxyribose-phosphate aldolase activity Regulated?

The expression and activity of deoxyribose-phosphate aldolase (DERA) are regulated at multiple levels. In humans, DERA is upregulated in response to stress conditions, indicating transcriptional regulation. In bacteria, the deo operon, which includes the dra gene, is often controlled by deoxyribose availability and catabolite repression. Additionally, the enzyme's activity can be modulated by pH and temperature, as shown for Bacillus cereus and Paenibacillus sp. DERA. No allosteric regulators have been reported, but substrate availability is a key determinant of flux through the pathway.

deoxyribose-phosphate aldolase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
DERA (human)Stress response and nucleotide homeostasisDERA knockout HEK293 cells
deaD (Streptococcus suis)Bacterial infectionStreptococcus suis deaD mutant
dra (Bacillus cereus)Deoxyribose utilizationBacillus cereus dra knockout
DERA (Mycobacterium tuberculosis)TuberculosisM. tuberculosis DERA knockdown
DERA (engineered)Biocatalysis for (R)-1,3-butanediolE. coli overexpression strains
Cancer and Nucleotide Metabolism
Altered deoxyribose metabolism can affect nucleotide pools and DNA synthesis, processes relevant to cancer cell proliferation. Although direct links between DERA mutations and cancer are not well established, the enzyme's role in deoxyribose salvage may influence chemosensitivity.
Bacterial Infections
Pathogenic bacteria such as Streptococcus suis and Mycobacterium tuberculosis rely on deoxyribose catabolism for survival. DERA is therefore considered a potential target for novel antibacterial agents.
Metabolic Disorders
Inborn errors in deoxyribose metabolism are rare, but DERA dysfunction could contribute to imbalances in deoxyribonucleotide pools, potentially affecting tissue homeostasis.

From deoxyribose-phosphate aldolase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does DERA loss affect stress survival?DERA knockout cell line (e.g., HEK293)
What is the catalytic role of Lys167?Point mutation (K167A) in DERA
Can DERA be targeted for antibacterial therapy?Conditional knockout in Streptococcus suis
How does DERA contribute to deoxyribose catabolism?Knockout in Bacillus cereus
Can DERA be engineered for novel substrate specificity?Overexpression of mutant DERA in E. coli
Does DERA localize to specific cellular compartments?Tagged knock-in (GFP-DERA)

How to Study the deoxyribose-phosphate aldolase activity Process

MethodWhat It MeasuresTypical Application
Coupled enzymatic assayAldolase activity via NADH consumptionKinetic characterization
X-ray crystallographyThree-dimensional structureActive site analysis
Site-directed mutagenesisRole of specific residuesMechanistic studies
RT-qPCRmRNA expression levelsStress response
Western blotProtein expressionOverexpression validation
HPLCSubstrate and product quantificationBiocatalysis
Isothermal titration calorimetryBinding affinitySubstrate specificity
Circular dichroismProtein foldingStability studies
Enzymatic Activity Assays
Deoxyribose-phosphate aldolase activity is typically measured spectrophotometrically by coupling the formation of D-glyceraldehyde 3-phosphate to NADH oxidation via glyceraldehyde-3-phosphate dehydrogenase, or by detecting acetaldehyde using alcohol dehydrogenase. These assays allow determination of kinetic parameters such as Km and kcat.
Structural Biology
X-ray crystallography and site-directed mutagenesis have been used to elucidate the active site architecture of DERA from Streptococcus suis and other organisms, revealing key residues for substrate binding and catalysis.
Gene Expression Analysis
RT-qPCR and RNA-seq can quantify DERA mRNA levels under different conditions, such as stress or varying deoxyribose concentrations. This helps identify regulatory mechanisms.
Protein Purification and Characterization
Recombinant DERA can be overexpressed in E. coli, purified by affinity chromatography, and characterized for optimal pH, temperature, and substrate specificity.

How CRISPR Can Be Used to Study GO:0004139 deoxyribose-phosphate aldolase activity

Knockout

CRISPR-Cas9 knockout of DERA in human cell lines (e.g., HEK293) can reveal its role in stress responses and deoxyribose metabolism. In bacteria, knockout of the dra gene allows assessment of growth on deoxyribose as a sole carbon source.

Point Mutation

Introducing point mutations such as K167A in the DERA active site can abolish catalytic activity, confirming the essential role of the conserved lysine in Schiff base formation. Such mutants are valuable for mechanistic studies.

Knock-in

Knock-in of a tagged DERA (e.g., GFP-DERA) enables live-cell imaging and localization studies, helping to determine whether DERA is cytoplasmic or associated with specific organelles.

Overexpression

Overexpression of DERA in E. coli or other hosts is used for large-scale enzyme production and biocatalysis, including the synthesis of (R)-1,3-butanediol. Overexpression can also be used to study the effects of elevated DERA levels on cellular metabolism.

How EDITGENE Supports deoxyribose-phosphate aldolase activity Research

Researchers studying deoxyribose-phosphate aldolase activity-related genes often need to determine whether a candidate gene is causally involved in deoxyribose metabolism, stress responses, or biocatalytic pathways. EDITGENE provides comprehensive CRISPR-based services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for deoxyribose-phosphate aldolase activity research.

Frequently Asked Questions About deoxyribose-phosphate aldolase activity

It is an enzyme activity (GO:0004139) that catalyzes the reversible cleavage of 2-deoxy-D-ribose 5-phosphate into D-glyceraldehyde 3-phosphate and acetaldehyde.
The main gene is DERA in humans, and its homologs in bacteria such as dra in Bacillus cereus and deaD in Streptococcus suis.
Human DERA is the deoxyribose phosphate aldolase and is involved in stress responses and deoxyribose metabolism.
It is typically measured using coupled enzymatic assays that detect the formation of D-glyceraldehyde 3-phosphate or acetaldehyde.
DERA uses a conserved lysine to form a Schiff base with the substrate, followed by aldol cleavage to release products.
Yes, bacterial DERA enzymes are considered potential targets for antibacterial development, especially in pathogens like Streptococcus suis.
Yes, DERA is used for stereoselective carbon-carbon bond formation, such as in the synthesis of (R)-1,3-butanediol.
Synonyms include deoxyriboaldolase activity, phosphodeoxyriboaldolase activity, and 2-deoxyribose-5-phosphate aldolase activity.
DERA is found in bacteria, archaea, and eukaryotes, including humans.
CRISPR can create DERA knockout, point mutant, knock-in, or overexpression models to study its function in cells.

Conclusion

Deoxyribose-phosphate aldolase activity (GO:0004139) is a fundamental enzymatic function in deoxyribose metabolism with broad relevance from bacterial pathogenesis to human stress responses and industrial biocatalysis. The enzyme DERA and its homologs have been extensively characterized, providing a solid foundation for mechanistic and applied research. CRISPR-based models are powerful tools to further dissect its roles and to engineer improved variants for biotechnology.

References

  1. 1. Feng W et al.. 2026. Characterization of 2-deoxyribose-5-phosphate aldolase from Bacillus altitudinis JYY-02.. Braz J Microbiol 57(1) PMID: 42593628
  2. 2. Salleron L et al.. 2014. DERA is the human deoxyribose phosphate aldolase and is involved in stress response.. Biochim Biophys Acta 1843(12):2913-25 PMID: 25229427
  3. 3. Sgarrella F et al.. 1992. Deoxyribose 5-phosphate aldolase of Bacillus cereus: purification and properties.. Biochim Biophys Acta 1118(2):130-3 PMID: 1730028
  4. 4. Cao TP et al.. 2016. Structural insight for substrate tolerance to 2-deoxyribose-5-phosphate aldolase from the pathogen Streptococcus suis.. J Microbiol 54(4):311-21 PMID: 27033207
  5. 5. Kim T et al.. 2020. Rational engineering of 2-deoxyribose-5-phosphate aldolases for the biosynthesis of (R)-1,3-butanediol.. J Biol Chem 295(2):597-609 PMID: 31806708
  6. 6. DeSantis G et al.. 2003. Structure-based mutagenesis approaches toward expanding the substrate specificity of D-2-deoxyribose-5-phosphate aldolase.. Bioorg Med Chem 11(1):43-52 PMID: 12467706
  7. 7. You ZY et al.. 2013. Characterization and application of a newly synthesized 2-deoxyribose-5-phosphate aldolase.. J Ind Microbiol Biotechnol 40(1):29-39 PMID: 23179467
  8. 8. Kim YM et al.. 2010. Expression and characterization of a novel deoxyribose 5-phosphate aldolase from Paenibacillus sp. EA001.. J Microbiol Biotechnol 20(6):995-1000 PMID: 20622498
Contact Us
*
*
*
*
How did you hear about us: